GlassScriptPrepare for your visit
Andrzej P Stypko
Family Medicine · Uvalde, TX · NPI 1114026598
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,755.55
in general payments reported to CMS, 2019-2025 · $295 in 2025
The $295 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Smith+Nephew, INC. $458.77
- Melinta Therapeutics, LLC $425.51
- Organogenesis INC. $301.97
- Integra Lifesciences Corporation $145.66
- Kerecis Limited $145.08
- Abbvie INC. $54.37
Drugs and devices associated with these payments
Kimyrsa Kerecis Omega3 Marigen Kerecis Surgiclose Puraply Micromatrix Dalvance Invia Motion Endure Pcd-52 737a (US) White Pcd-51 731a (US) - White Lympha Press Optimal Plus(US) Bt Integra Kerecis Omega3 Surgiclose
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Andrzej Stypko listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/5339/andrzej-p-stypko